Get started
Work

Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial

Year: 2018
Type: article
DOI: 10.1093/annonc/mdy424.070
Authors: S. Popat, H.R. Kim, M.-J. Ahn, J.C.-H. Yang, J.-Y. Han, M.J. Hochmair, K.H. Lee, A. Delmonte, M.R. Garcia Campelo, D.-W. Kim, F. Griesinger, E. Felip, R. Califano, A.I. Spira, S. Gettinger, M. Tiseo, J. Haney, D. Kerstein, D.R. Camidge
Institutions: Royal Marsden Hospital, Yonsei University, Yonsei Cancer Hospital, Samsung Medical Center, National Taiwan University Hospital, National Cancer Center, National Cancer Center Hospital, Ludwig Boltzmann Institute for Lung Health, Chungbuk National University, Chungbuk National University Hospital, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Complexo Hospitalario Universitario A Coruña, Seoul National University Hospital, Pius Hospital Oldenburg, Vall d'Hebron Hospital Universitari, National Health Service, The Christie NHS Foundation Trust, Virginia Cancer Specialists, Yale Cancer Center, Takeda Oncology (United States), University of Colorado Cancer Center
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2898115533
FWCI: 0.762
Cites:
Cited by: 5
Related to: 10